Send me a link:

*Text messaging rates may apply.

 Dow Down0.90% Nasdaq Down0.73%

Esperion Therapeutics, Inc. (ESPR)

-NasdaqGM
14.15 Down 0.19(1.32%) 11:09AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development16,014  7,998  7,808  
Selling General and Administrative6,744  2,206  2,357  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (22,759) (10,204) (10,164)
Income from Continuing Operations
Total Other Income/Expenses Net(2,393)(51)(76)
Earnings Before Interest And Taxes(25,152)(10,255)(10,240)
Interest Expense937  1,487  577  
Income Before Tax(26,088)(11,742)(10,817)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(26,088)(11,742)(10,817)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (26,088) (11,742) (10,817)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (26,088) (11,742) (10,817)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.